Bintai Kinden’s partner files trademark for Covid-19 vaccine


KUALA LUMPUR: Bintai Kinden Corporation Bhd’s partner Generex Biotechnology Corporation has filed for a trademark for its li-Key vaccine and patent for its Ii-Key-SARS-CoV-2 vaccine.

In a statement issued on Thursday, Bintai Kinden said the Ii-Key vaccine was designed to be a complete vaccine for the Covid-19.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Trading ideas: Maybank, Capital A, Sapura Energy, Paragon, Atlan, Fajarbaru, Tiong Nam, T7, Carimin, Jati Tinggi, MCE, Heineken
Mida identifies 12 Egyptian companies interested in investing in Malaysia - Tengku Zafrul
Kelington posts RM33mil profit in 3Q24
Singapore project to lift Sunway’s 3Q24 earnings
Japan PM pledges fresh US$65bil aid for chips, AI
Maybank weighing options for insurer Etiqa
Guocoland braces for challenges
Uptrend in performance for construction players
Greater clarity on TNB’s floating solar project, hydropower station rehab
EPF dividend likely to top 6%

Others Also Read